Metabolomics Creative Proteomics
Sample Submission Guidelines Inquiry
Request a Quote

Targeted Metabolomics — Quantitative Panels for Precision Metabolite Analysis

We offer 50+ validated quantitative panels covering 500+ metabolites — each pre-optimized with scheduled MRM transitions, isotopically labeled internal standards, and matrix-matched calibration. From single-pathway panels (10-20 analytes) to comprehensive class-wide assays (80+ analytes), every panel delivers absolute concentration data with documented LOD, linearity, and batch QC — not relative abundance. Panels can be ordered individually or combined from a single sample extract. Custom panel development is available for targets not in the catalog.

50+ validated panels — 500+ metabolites with pre-optimized MRM transitions, ready to deploy

Absolute quantification — isotopically labeled internal standards and 8-point matrix-matched calibration

Flexible ordering — single panel, combined panels from one extract, or custom panel development

Full QC documentation — pooled QC RSD, IS recovery per sample, calibration R2, blank carryover assessment

Cross-platform — LC-MS/MS (SCIEX QTRAP 6500+, Thermo Q Exactive) + GC-MS/MS (Agilent 7890B-5977A, Thermo TSQ 9000)

Targeted Metabolomics — Quantitative MRM Panels Covering 500+ Metabolites Across All Major Metabolic Pathways

Targeted Metabolomics Panel Catalog by Metabolite Class

Each panel is a standalone, ready-to-order quantitative assay with a dedicated page listing its full analyte range, chromatograms, and sample requirements. Panels sharing the same platform and chromatography can be combined from one sample extract.

Central Carbon & Energy Metabolism

Panel Analytes Platform Key Analytes & Coverage Highlights
Central Carbon Metabolism 40+ LC-MS/MS Glycolysis (G6P, F6P, FBP, 3PG, PEP, pyruvate, lactate), TCA cycle (citrate, alpha-KG, succinate, fumarate, malate, oxaloacetate), pentose phosphate pathway (6PG, R5P, S7P), glyoxylate shunt intermediates; carbohydrate metabolism pathway coverage
Energy Metabolism 30+ LC-MS/MS Adenylates (ATP, ADP, AMP), nicotinamide cofactors (NAD+, NADH, NADP+, NADPH), CoA species (CoA-SH, acetyl-CoA, succinyl-CoA, malonyl-CoA), creatine/phosphocreatine, energy charge (AEC) calculation
Glycolysis Pathway 20+ LC-MS/MS Full glycolytic intermediates from glucose uptake to pyruvate/lactate; hexosamine pathway (GlcN-6P, UDP-GlcNAc); glycerol-3-phosphate shuttle; fructose and galactose feeding intermediates; fructose/mannose and galactose metabolism pathway intersections
TCA Cycle 15+ LC-MS/MS Complete TCA intermediates: citrate, isocitrate, alpha-KG, succinate, fumarate, malate, oxaloacetate; anaplerotic (pyruvate, glutamate, glutamine) and cataplerotic (aspartate, PEP, citrate export) nodes; TCA cycle flux ratios
Pentose Phosphate Pathway 15+ LC-MS/MS Oxidative phase (6PG, Ru5P, CO2) and non-oxidative phase (R5P, X5P, S7P, E4P); NADPH/NADP+ ratio; sedoheptulose and erythrose intermediates; PPP/glycolysis flux partitioning
Pyruvate Metabolism 10+ LC-MS/MS Pyruvate, lactate, alanine, acetyl-CoA; pyruvate dehydrogenase (PDH) and pyruvate carboxylase (PC) pathway readouts; Cori cycle intermediates; pyruvate fermentation products
Oxidative Phosphorylation 15+ LC-MS/MS ETC complex I-V substrates and products; NADH/NAD+, FADH2/FAD ratios; ATP synthase activity readouts via ATP/ADP ratio and energy charge (AEC); mitochondrial membrane potential markers; proton gradient indicators

Amino Acids & Nitrogen Metabolism

Panel Analytes Platform Key Analytes & Coverage Highlights
Amino Acids Profiling 80+ LC-MS/MS 20 proteinogenic amino acids plus 60+ non-proteinogenic AAs and derivatives: hydroxyproline, hydroxylysine, citrulline, ornithine, GABA, beta-alanine, 1-/3-methylhistidine, taurine, polyamines, neurotransmitter precursors, one-carbon and sulfur amino acid pathway metabolites
Branched-Chain Amino Acids (BCAA) 10+ LC-MS/MS Leucine, isoleucine, valine; BCKA (KIC, KMV, KIV); BCAA/AAA ratio; mTORC1 activation readout; muscle vs. plasma BCAA partitioning for catabolic state assessment; branched-chain keto acids (BCKA)
One-Carbon Metabolism 20+ LC-MS/MS Methionine cycle (methionine, SAM, SAH, homocysteine), folate cycle (THF, 5-MTHF, 5,10-MTHF, DHF), transsulfuration (cystathionine, cysteine, glutathione, taurine); betaine and choline methylation donors; SAM/SAH ratio
Urea Cycle 10+ LC-MS/MS Arginine, ornithine, citrulline, argininosuccinate, aspartate, fumarate, urea; urea cycle flux indicators; hyperammonemia metabolic signature; arginine bioavailability ratios (arginine/ornithine + citrulline)
Glutamine Metabolism 10+ LC-MS/MS Glutamine, glutamate, alpha-KG, GABA, asparagine, aspartate; glutaminolysis readout (glutamine-to-glutamate ratio); GLS vs. GDH pathway partitioning; glutamine synthetase activity markers; folate-dependent one-carbon intersections
Polyamines 10+ LC-MS/MS Putrescine, spermidine, spermine, cadaverine, agmatine, N-acetylspermidine, N-acetylspermine; ornithine decarboxylase (ODC) activity readout; polyamine biosynthesis and interconversion pathway coverage; arginine/ornithine precursor readout

Lipids, Fatty Acids & Steroids

Panel Analytes Platform Key Analytes & Coverage Highlights
Fatty Acids Profiling 40+ GC-MS SCFAs (C2-C7), MCFAs (C8-C12), LCFAs (C14-C24); saturated, monounsaturated, and polyunsaturated (n-3 ALA/EPA/DHA, n-6 LA/AA, n-9 series); odd-chain fatty acids; trans fatty acids; omega-3/omega-6 ratio; alpha-linolenic and linoleic acid metabolism pathways
Free Fatty Acids 30+ LC-MS/MS Unesterified/non-esterified fatty acids (NEFA/FFA) in plasma, serum, and tissue; lipolysis readout; adipose-liver-muscle FFA flux markers; albumin-bound fatty acid fraction; unsaturated fatty acid biosynthesis and de novo fatty acid synthesis pathway coverage
Short-Chain Fatty Acids (SCFA) 15+ GC-MS Acetate, propionate, butyrate, isobutyrate, valerate, isovalerate, caproate, heptanoate; branched-chain SCFAs; lactic acid, succinic acid, formic acid; beta-hydroxybutyrate; microbiome fermentation readout with 0.01-0.10 uM LOD; butanoate and propanoate metabolism pathway context
Bile Acids 20+ LC-MS/MS Primary (CA, CDCA), secondary (DCA, LCA, UDCA), and conjugated (glycine, taurine) bile acids; total and individual species; unconjugated/conjugated ratio; FXR and TGR5 signaling readout; isomer-resolved quantification; primary bile acid biosynthesis pathway coverage
Arachidonic Acid Cascade 15+ LC-MS/MS Arachidonic acid, prostaglandins (PGE2, PGD2, PGF2alpha), thromboxanes (TXB2, TXA2), leukotrienes (LTB4, LTC4, LTD4, LTE4), HETEs (5-HETE, 12-HETE, 15-HETE), EETs; COX-1/COX-2, 5-LOX/12-LOX/15-LOX, and CYP450 epoxygenase/hydroxylase pathway coverage; pro-/anti-inflammatory lipid mediator balance; ether lipid and sphingolipid pathway intersections
Steroid Hormone Panel 20+ LC-MS/MS Corticosteroids (cortisol, corticosterone, aldosterone, 11-deoxycortisol, cortisone), androgens (testosterone, DHT, androstenedione, DHEA, DHEA-S), estrogens (estradiol, estrone, estriol, 2-/4-/16-hydroxyestrone), progestogens (progesterone, 17-OH-progesterone, pregnenolone); steroidogenic pathway ratios; steroid biosynthesis and steroid hormone pathway coverage

Nucleotides, Cofactors & Specialized Mammalian Panels

Panel Analytes Platform Key Analytes & Coverage Highlights
Nucleotide Metabolism 30+ LC-MS/MS Purines (AMP, ADP, ATP, GMP, GDP, GTP, IMP, XMP, uric acid), pyrimidines (UMP, UDP, UTP, CMP, CDP, CTP, TMP, TDP, TTP); de novo vs. salvage pathway readout; energy charge (ATP/ADP/AMP ratio); deoxynucleotide pools (dATP, dGTP, dCTP, dTTP); nucleotide, purine, and pyrimidine pathway coverage
Purine Metabolism 20+ LC-MS/MS IMP, AMP, GMP, XMP, adenosine, guanosine, inosine, hypoxanthine, xanthine, uric acid; de novo purine biosynthesis intermediates (PRPP, GAR, FGAR, AIR, SAICAR, AICAR, IMP); xanthine oxidase and HGPRT salvage readout; allantoin for uricase-expressing species
Pyrimidine Metabolism 15+ LC-MS/MS UMP, CMP, TMP, dTMP, uridine, cytidine, thymidine, deoxyuridine, uracil, cytosine, thymine; dihydroorotate and orotate; CAD (CPS II, ATCase, DHOase) and DHODH pathway readout; pyrimidine salvage vs. de novo synthesis partitioning; 5-FU pharmacodynamic markers
Cyclic Nucleotides 5+ LC-MS/MS cAMP, cGMP, cGAMP (2'3'-cGAMP, 3'3'-cGAMP); adenylyl cyclase (AC1-9) and guanylyl cyclase (sGC, pGC) activity readout; phosphodiesterase (PDE1-11) pathway markers; STING pathway cGAMP signaling; intracellular second messenger quantification with sub-nM sensitivity
Cofactors & Vitamins 30+ LC-MS/MS Nicotinamide cofactors (NAD+, NADH, NADP+, NADPH, NaMN, NaAD), CoA/acyl-CoAs (free CoA, acetyl-CoA, malonyl-CoA, succinyl-CoA, propionyl-CoA), FAD/FMN, SAM/SAH, THF species, PLP; vitamins: B1 (thiamine/TDP), B2 (riboflavin/FAD/FMN), B3 (nicotinate/nicotinamide), B5 (pantothenate), B6 (pyridoxal/pyridoxamine/pyridoxic acid), B7 (biotin), B9 (folate/5-MTHF), B12 (methylcobalamin/adenosylcobalamin); vitamins A (retinol/retinal/retinoic acid), D (25-OH-D2/D3, 1,25-(OH)2-D2/D3), E (alpha/beta/gamma/delta-tocopherols and tocotrienols), K (phylloquinone/menaquinones); thiamine, riboflavin, vitamin B6, nicotinate/nicotinamide, biotin, folate, retinol, lipoic acid sub-pages
Organic Acids 50+ GC-MS TCA cycle intermediates, glycolytic products (lactate, pyruvate), ketone bodies (acetoacetate, beta-hydroxybutyrate, acetone), dicarboxylic acids, phenolic acids, hippuric acid, microbial metabolites (phenylacetylglutamine, p-cresol sulfate, indoxyl sulfate); inborn errors of metabolism markers; urine organic acid profiling
Neurotransmitters 20+ LC-MS/MS Catecholamines (dopamine, norepinephrine, epinephrine, metanephrine, normetanephrine), serotonin (5-HT) and 5-HIAA, histamine and N-methylhistamine, GABA, glutamate, aspartate, glycine, acetylcholine; monoamine turnover ratios (HVA/dopamine, 5-HIAA/5-HT, MHPG/norepinephrine); tyrosine and tryptophan hydroxylase pathway readout; monoamine and catecholamine sub-panels
Animal Hormones 15+ LC-MS/MS Thyroid hormones (T3, T4, rT3, TBG), metabolic hormones (insulin, C-peptide, glucagon, leptin, adiponectin, resistin, ghrelin), stress hormones (cortisol, corticosterone, ACTH, CRH), reproductive hormones (estradiol, progesterone, testosterone, FSH, LH, prolactin, AMH), growth axis (GH, IGF-1, IGFBP-3), bone metabolism (PTH, calcitonin, osteocalcin); multi-species (mouse, rat, canine, NHP, livestock)
Mevalonate Pathway & Isoprenoids 15+ LC-MS/MS HMG-CoA, mevalonate, mevalonate-5P, isopentenyl-PP, dimethylallyl-PP, geranyl-PP, farnesyl-PP, geranylgeranyl-PP, squalene, lanosterol, desmosterol, cholesterol, 7-dehydrocholesterol, ubiquinone (CoQ10), dolichol; statin pharmacodynamic readout; cholesterol biosynthesis intermediates and protein prenylation markers; ubiquinone biosynthesis pathway
Immunometabolism 50+ LC-MS/MS Immune cell metabolic reprogramming markers (glycolysis/OXPHOS balance): itaconate, 2-hydroxyglutarate (L/D), succinate, fumarate, citrate; tryptophan/kynurenine pathway (kynurenine, kynurenic acid, 3-hydroxykynurenine, quinolinic acid, picolinic acid); arginine metabolism (arginine, ornithine, citrulline, polyamines, proline); M1/M2 macrophage metabolic polarization readout (iNOS/arginase balance, itaconate/succinate ratio); T cell activation metabolic signature (glutaminolysis, aerobic glycolysis); IDO1/TDO and arginase activity surrogates; tryptophan and kynurenine pathway

Plant & Natural Product Panels

Panel Analytes Platform Key Analytes & Coverage Highlights
Plant Hormones 100+ LC-MS/MS & GC-MS/MS Auxins (IAA, IBA, 4-Cl-IAA, oxIAA), cytokinins (tZ, cZ, DZ, iP, and riboside/ribotide forms), gibberellins (GA1, GA3, GA4, GA7, GA9, GA12, GA20, GA53), ABA and degradation products (PA, DPA, neoPA, ABA-GE), brassinosteroids (BL, CS, 28-homoBL, TE, TY), jasmonates (JA, JA-Ile, OPDA, MeJA, 12-OH-JA), salicylic acid and SAG, strigolactones (5-DS, orobanchol, strigol), ethylene precursor (ACC), melatonin; auxin, cytokinin, gibberellin, ABA, brassinosteroid, jasmonate, salicylic acid, strigolactone, ethylene, melatonin sub-pages
Carotenoids 20+ LC-MS/MS Carotenes (alpha-carotene, beta-carotene, lycopene, phytoene, phytofluene), xanthophylls (lutein, zeaxanthin, beta-cryptoxanthin, astaxanthin, canthaxanthin, capsanthin, capsorubin, violaxanthin, neoxanthin, fucoxanthin); apo-carotenoids (bixin, crocetin); vitamin A activity equivalents (retinol, retinyl esters)
Chlorophyll 6+ LC-MS/MS Chlorophyll a, b, c1, c2, d, f; degradation products (pheophytin a/b, pheophorbide a/b, chlorophyllide a/b, pyropheophytin); chlorophyll a, b, c1, c2, d, f sub-pages; porphyrin/chlorophyll metabolism pathway
Flavonoids 50+ LC-MS/MS Flavonols (quercetin, kaempferol, myricetin, isorhamnetin), flavones (apigenin, luteolin, chrysin, baicalein, baicalein, baicalin), flavanones (naringenin, naringenin, hesperetin, eriodictyol, homoeriodictyol), isoflavones (genistein, daidzein, glycitein, formononetin), anthocyanins (cyanidin, delphinidin, pelargonidin, peonidin, petunidin, malvidin glycosides; anthocyanins), proanthocyanidins (catechins, catechin, epicatechin, procyanidins B1/B2); O- and C-glycosylated flavonoids (O-glycosylated, C-glycosylated)
Polyphenols 100+ LC-MS/MS Phenolic acids (gallic acid, chlorogenic acid, caffeic acid, ferulic acid, p-coumaric acid, cinnamic acid, rosmarinic acid, ellagic acid), flavonoids (as listed in Flavonoids panel above), stilbenes (resveratrol, pterostilbene, piceatannol, rhaponticin, salvianic acid), lignans, hydrolyzable and condensed tannins (tannic acid); food, beverage, herbal medicine, and plant extract matrices
Saponins 20+ LC-MS/MS Triterpenoid saponins (ginsenosides Rb1/Rb2/Rc/Rd/Re/Rf/Rg1/Rg2/Rg3/Rh1/Rh2, ginsenosides; glycyrrhizic acid; escin; asiaticoside) and steroidal saponins (diosgenin, sarsasapogenin, solasodine; soyasaponins A/B); glycoalkaloids (alpha-solanine, alpha-chaconine, tomatine); herbal medicine, food, and plant tissue matrices
Alkaloids 30+ LC-MS/MS Indole alkaloids (vinblastine, vincristine, yohimbine, reserpine, strychnine, brucine), tropane alkaloids (atropine, scopolamine, cocaine), isoquinoline alkaloids (berberine, palmatine, morphine, codeine, sanguinarine, chelerythrine), purine alkaloids (caffeine, theobromine, theophylline), steroidal alkaloids (solasodine, tomatidine, cyclopamine, veratridine); plant, herbal medicine, and food safety matrices
Terpenoids 20+ GC-MS/MS Monoterpenoids (limonene, menthol, camphor, thymol, carvacrol, linalool, geraniol, pinene), sesquiterpenoids (farnesol, artemisinin, parthenolide, beta-caryophyllene, cedrol), diterpenoids (taxol/paclitaxel, forskolin, stevioside, gibberellic acid precursors), triterpenoids (ursolic acid, oleanolic acid, betulinic acid, lupeol, squalene-derived); essential oil, resin, and plant extract matrices
Tannins 15+ LC-MS/MS Hydrolyzable tannins — gallotannins (gallic acid, pentagalloylglucose) and ellagitannins (ellagic acid, punicalagin, punicalin, sanguiin H-6, vescalagin, castalagin); condensed tannins/proanthocyanidins (procyanidins B1/B2/B3/C1, prodelphinidins, propelargonidins; catechin, epicatechin, epigallocatechin, gallocatechin oligomers and polymers); food, feed, beverage, and plant tissue matrices
Lignans 15+ LC-MS/MS & GC-MS/MS Secoisolariciresinol, matairesinol, pinoresinol, lariciresinol, medioresinol, syringaresinol, sesamin, sesamolin, hydroxymatairesinol, arctiin/arctigenin, phillyrin, isotaxiresinol, cubebin; enterolactone and enterodiol (mammalian gut microbial metabolites); plant, food, and biological matrices
Coumarins 10+ LC-MS/MS Simple coumarins (coumarin, umbelliferone, esculetin, scopoletin, herniarin), furanocoumarins (psoralen, bergapten, xanthotoxin, imperatorin, angelicin), pyranocoumarins (xanthyletin, seselin, khellactone), dicoumarol anticoagulants (dicoumarol, warfarin, acenocoumarol); plant, food, and pharmacological matrices
Stilbenes 10+ LC-MS/MS Resveratrol (trans- and cis-), pterostilbene, piceatannol (astringinin), rhaponticin (rhapontin), piceid (polydatin), viniferins (alpha-, beta-, delta-, epsilon-viniferin), hopeaphenol, ampelopsin; glycosylated and sulfated conjugates; grape, wine, berry, peanut, and medicinal plant matrices
Volatilomics (VOC Profiling) 100+ GC-MS (HS-SPME) VOCs — hydrocarbons, alcohols, aldehydes, ketones, esters, ethers, terpenes, sulfur compounds, nitrogen compounds, halogenated compounds; HS-SPME-GC-MS profiling across plant volatilome (aroma, stress response), food flavor/aroma, microbial mVOCs, environmental VOC monitoring; RI-confirmed identification against NIST/Wiley libraries

Analytical Platforms for Targeted Metabolomics

LC-MS/MS

SCIEX QTRAP 6500+ — Triple quadrupole/linear ion trap with scheduled MRM for targeted quantification. HILIC (polar metabolites) and reversed-phase C18 (lipids, non-polar) in both ESI modes. Quantifies 100+ analytes per run with sub-nM LOD.

AB SCIEX TripleTOF 5600 — Q-TOF for method development and structural confirmation. SWATH DIA for comprehensive MS/MS. Mass accuracy below 2 ppm.

Thermo Q Exactive Orbitrap — Resolution 140,000 FWHM with HCD fragmentation. Used for panel development, isomer resolution, and unknown metabolite identification in custom projects.

GC-MS/MS & NMR

Agilent 7890B-5977A GC-MS — EI source with DB-5MS/DB-FFAP columns. SIM for targeted volatile/derivatized metabolites, full scan for untargeted. Covers organic acids, sugars, fatty acids, sterols.

Thermo TSQ 9000 GC-MS/MS — Triple quadrupole with SRM for low-abundance volatiles (EI and CI modes). Sub-nM sensitivity for SCFA, VOC, and terpenoid panels.

Bruker Avance 600/800 MHz NMR — 1D 1H-NMR for biofluid profiling without derivatization. 2D NMR (HSQC, TOCSY) for structural elucidation in custom method development.

SCIEX QTRAP 6500+ LC-MS/MS System for Targeted Metabolomics MRM Quantification

SCIEX QTRAP 6500+ (Figure from SCIEX)

Thermo Q Exactive Orbitrap LC-MS for Targeted Panel Development

Thermo Q Exactive Orbitrap (Figure from Thermo)

Agilent 7890B-5977A GC-MS System for Targeted Volatile Metabolite Quantification

Agilent 7890B-5977A GC-MS (Figure from Agilent)

Waters ACQUITY UPLC System for Targeted Metabolomics Chromatography

Waters ACQUITY UPLC System (Figure from Waters)

Method Validation & Quality Control

  • MRM Assay Development — 2-3 optimized transitions per analyte (quantifier + qualifier) from MS/MS spectra. CE, DP, and RT windows optimized per compound. All transitions validated against authentic chemical standards on SCIEX QTRAP 6500+ or Thermo Q Exactive platforms.
  • Isotopically Labeled Internal Standards — Matched 13C/15N/D-labeled IS spiked at the earliest preparation step. Corrects for extraction efficiency, derivatization yield, ion suppression, and instrument drift.
  • 8-Point Matrix-Matched Calibration — Calibrators in the same matrix as study samples, 3-4 orders of magnitude, 1/x2 weighted regression. R2 above or equal to 0.99. Calibrator back-calculated accuracy: within plus or minus 15% (plus or minus 20% at LLOQ).
  • Batch QC System — Pooled QCs injected every 8-10 samples. RSD below 15% acceptance. QC-LOESS drift correction. ComBat for multi-batch studies. Blank carryover below 1% of LLOQ.
  • Precision & Accuracy — Intra-batch CV below 5% (major analytes), below 10% (low-abundance). Inter-batch CV below 15%. Spike recovery: 85-115% at low/mid/high QC levels.
  • Panel Validation Status — Standard panels: full validation (LOD, LLOQ, linear range, precision, recovery) for plasma/serum, tissue, urine. Custom panels: fit-for-purpose validation with calibration, precision, and matrix effect assessment.

Targeted Metabolomics Workflow

1

Panel Selection & Study Design

Select panels from the catalog, combine multiple panels, or define custom targets. We review your biological question, sample type, and expected concentration ranges to confirm panel fit and recommend sample size (n above or equal to 5 per group) before you ship samples.

2

Sample Preparation & IS Addition

Samples received frozen on dry ice, integrity confirmed within 1 business day. Matrix-specific extraction with isotopically labeled IS cocktail spiked at homogenization. Calibrators and QCs prepared in parallel from identical stock solutions.

3

LC-MS/MS or GC-MS/MS MRM Acquisition

Scheduled MRM on SCIEX QTRAP 6500+ or SIM/SRM on GC-MS/MS. Sequence: blank, 8 calibrators, pooled QC, randomized study samples with QC every 8-10 injections. Multi-batch studies use bridging QCs for inter-batch normalization.

4

Data Processing & QC Review

Automated peak integration (SCIEX OS / MassHunter) with manual analyst review. 1/x2 weighted calibration; IS-normalized concentrations. QC review: pooled QC RSD, IS recovery, blank carryover, calibration R2 per analyte. Failing analytes flagged with explanatory comments.

5

Report Delivery

Concentration table (uM, nmol/g) in Excel/CSV. QC report with calibration curves, IS recovery, precision. Methods documentation for manuscript. Optional: statistical analysis (FDR, PCA, PLS-DA), pathway enrichment, publication-ready figures (300 DPI TIFF + PDF). Raw instrument files on request.

Targeted Metabolomics Workflow — Five-Step Pipeline from Panel Selection to Quantitative Data Delivery

Custom Panel Design — Targets Not in Our Catalog

  • Feasibility Assessment — Review your target list against our MS/MS spectral library (150+ verified metabolites). Identify authentic standards and labeled IS. Assess ionization, chromatography, and expected LOD. Report within 5 business days.
  • Method Development — Optimize MRM transitions, chromatography (HILIC vs. RP C18), collision energy, and ion source parameters. Validate extraction recovery from your sample matrix.
  • Fit-for-Purpose Validation — Calibration linearity (R2 above or equal to 0.99), precision at 2 levels (CV below 15%), LOD/LLOQ, matrix effects, processed sample stability (24 h at 4 degree C). Full report with first batch.

Common custom requests fulfilled:

  • Species-specific metabolites — D-amino acids, plant secondary metabolites (glucosinolates, phenylpropanoids), microbial siderophores and quorum sensing molecules
  • Drug & xenobiotic panels — Parent drug + phase I/II metabolites for ADME/PK; CYP450 phenotyping; environmental exposure panels (phthalates, PFAS, pesticides)
  • Expanded pathway coverage — Add 5-20 analytes to an existing standard panel (e.g., glucuronidated bile acids, acetylated polyamines)
  • Unusual matrices — CSF (ultra-low volume), vitreous humor, synovial fluid, amniotic fluid, bone marrow aspirate, dried blood spots, BAL fluid, microdialysate

Applications of Targeted Metabolomics Panels

Biomarker Validation

Move from untargeted discovery to absolute quantification. Calibrated concentrations (uM, ng/mL) for translational research, cross-study meta-analysis, and biomarker qualification.

Drug Metabolism & PK

Parent drug and metabolite concentrations in plasma, liver, target tissues. CYP450 phenotyping. Acyl-carnitine profiling for mitochondrial toxicity screening.

Nutritional Metabolomics

Quantify vitamins, amino acids, fatty acids, and energy metabolites before and after dietary intervention. Nutrient status, bioavailability, supplement efficacy.

Metabolic Disease Research

TCA cycle, acylcarnitines, amino acids, and bile acids in diabetes, obesity, NAFLD/NASH. Insulin resistance signatures. Inter-organ metabolite flux.

Neurochemistry

Neurotransmitters and metabolites in brain tissue, CSF, microdialysate. Monoamine, amino acid, and neuropeptide panels. BBB permeability via plasma/CSF ratios.

Microbiome-Host Interaction

SCFA, bile acid, and tryptophan metabolite panels for gut microbiome functional readout. TMAO and uremic toxin quantification from fecal samples.

Plant & Crop Science

Plant hormone profiling, carotenoid and chlorophyll quantification, polyphenol and flavonoid characterization. Stress response, nutritional quality, breeding trait markers.

Multi-Omics Integration

Pair quantitative metabolomics with transcriptomics, proteomics, or metagenomics. Integrated pathway maps showing multi-omics evidence across metabolomics, proteomics, and transcriptomics.

Deliverables — What You Receive

  • Quantitative Concentration Table — Absolute concentrations for each analyte per sample. Excel and CSV. LLOQ/LOD flags, IS recovery, and QC acceptance flags per sample.
  • QC Report — Calibration curves (8-point, 1/x2 weighted, R2 and back-calculated accuracy). Pooled QC RSD per analyte. IS recovery per sample (80-120% window). Blank carryover. Inter-batch bridging QC for multi-batch studies.
  • Methods Documentation — Complete acquisition parameters (column, gradient, MRM transitions, ion source), sample preparation protocol, data processing parameters and software versions. Formatted for manuscript methods section.
  • Optional Statistical Analysis — Univariate (t-test/ANOVA, FDR, volcano/box plots), multivariate (PCA, PLS-DA/OPLS-DA with permutation testing, VIP scores), pathway enrichment (ORA + MSEA, KEGG/Reactome). Publication-ready figures (300 DPI TIFF + vector PDF/AI).

Data Visualizations

Targeted Metabolomics MRM Chromatogram — Scheduled MRM Peaks with Internal Standard Overlay Showing Chromatographic Resolution

Scheduled MRM chromatogram: analyte peaks with co-eluting IS, demonstrating chromatographic resolution and RT stability.

Targeted Metabolomics 8-Point Matrix-Matched Calibration Curve with 1/x2 Weighted Regression

8-point matrix-matched calibration curve, 1/x2 weighted regression (R2 above or equal to 0.99), LOD/LLOQ indicated.

Targeted Metabolomics QC Metrics — Pooled QC RSD Distribution and IS Recovery Per Sample

QC summary: per-analyte RSD distribution from pooled QCs (left), IS recovery per sample with 80-120% limits (right).

Targeted Metabolomics Quantitative Data — Group Comparison Box Plots and KEGG Pathway Map

Quantitative data: box plots of absolute concentrations across groups with FDR significance (left), KEGG pathway map (right).

Case Study — Targeted Amino Acid Profiling Identifies Dopaminergic Pathway Deficits in a Genetic Mouse Model

Central biogenic amine deficiency with concomitant exploratory behavioral deficits in Dnajc12 knock-out mice

Deng, I.B., et al. | NPJ Parkinson's Disease, 2025, 11, 42 | IF: 8.2

DOI: 10.1038/s41531-025-00991-4


Research Question

Dnajc12 is a co-chaperone highly expressed in dopaminergic neurons, but its in vivo role in dopamine synthesis was unknown. Researchers needed to simultaneously quantify free amino acids, neurotransmitter precursors, and biogenic amines in Dnajc12 knockout (DKO) mouse plasma — requiring a targeted panel sensitive enough to distinguish structurally similar metabolites (dopamine vs. norepinephrine, phenylalanine vs. tyrosine) at endogenous concentrations.

How Targeted Metabolomics Answered It

Plasma from DKO and WT mice was analyzed using a targeted UPLC-MRM/MS panel on a SCIEX QTRAP 6500 Plus with heated ESI source. The panel simultaneously quantified free amino acids, biogenic amines, and related metabolites — using isotopically labeled IS for absolute quantification and scheduled MRM for isomer-specific detection.

Measurement Key Finding
Targeted UPLC-MRM/MS Amino Acid & Biogenic Amine Panel DKO mice showed significant reductions in plasma phenylalanine and tyrosine — dopamine precursors — and elevated citrulline, ornithine, arginine (compensatory urea cycle shifts). Serotonin and tryptophan were also significantly altered.
Isomer-Specific MRM Quantification Baseline chromatographic separation of isobaric dopamine, norepinephrine, and related catecholamines enabled confident individual quantification — these structurally similar metabolites cannot be distinguished by MS/MS alone without chromatographic resolution.

Analytical Approach We Replicate

This study demonstrates the framework our panels deliver: (1) pre-optimized MRM transitions with isomer-resolving chromatography; (2) isotopically labeled IS for absolute quantification; (3) a single panel extracting maximum biological insight from limited sample volume — connecting amino acid metabolism, neurotransmitter synthesis, and urea cycle function from one analysis.

Reference

  1. Deng, I.B., et al. Central biogenic amine deficiency with concomitant exploratory behavioral deficits in Dnajc12 knock-out mice. NPJ Parkinson's Disease 11, 42 (2025).

Frequently Asked Questions

What is the difference between targeted and untargeted metabolomics?

Targeted metabolomics uses triple quadrupole MS in MRM mode for absolute quantification of predefined metabolite panels with isotopically labeled internal standards for every analyte. Results are calibrated concentrations (uM, nmol/g). Untargeted metabolomics uses high-resolution MS to profile all detectable features without pre-selection — ideal for discovery but semi-quantitative (relative peak areas). Most projects use untargeted for discovery followed by targeted panels for validation from the same sample extract.

How many metabolites can you quantify per panel?

Panel size ranges from 10-20 (single-pathway: TCA Cycle, Urea Cycle) to 80+ (comprehensive: Amino Acids, Polyphenols). Multiple panels using the same chromatography can be combined from one extract. The catalog covers 500+ metabolites across 50+ panels. Custom panels expand coverage to new targets.

What are the detection limits?

Typical LOD: sub-nM to low uM depending on analyte and matrix. LC-MS/MS (SCIEX QTRAP 6500+): sub-nM to nM for most analytes. GC-MS: nM to uM (EI), sub-nM (SRM on triple quad). Linear range spans 3-4 orders of magnitude with R2 above or equal to 0.99. Each panel's LOD/LLOQ documented in the validation report. Request specific LOD data for your analytes during consultation.

How do you ensure truly quantitative (not semi-quantitative) results?

Three elements: (1) isotopically labeled IS spiked at the earliest prep step; (2) 8-point matrix-matched calibration with 1/x2 weighted regression; (3) pooled QCs every 8-10 injections with RSD below 15% acceptance. Without all three, concentrations are semi-quantitative. Every QC metric documented in your report.

Can I create a custom panel?

Yes. Process: (1) feasibility assessment against our MS/MS library and available standards (5 business days); (2) method development — optimize MRM transitions, chromatography, extraction; (3) fit-for-purpose validation — calibration linearity, precision, LOD/LLOQ, matrix effects. Custom panels require 2-4 weeks for development before sample analysis.

What sample types do you accept?

Standard matrices: plasma/serum, tissue homogenate (liver, brain, heart, kidney, muscle), urine. Additional: CSF (5-50 uL), cell pellets (1-5 x 10^6 cells), feces, bile, synovial fluid, whole blood, DBS, cell culture media, fermentation broth, food/plant extracts. Requirements: biofluids 25-500 uL, tissue 20-200 mg, cells 1-5 x 10^6. Matrix effect assessment included for unusual matrices.

How long does analysis take?

Standard: 2-3 weeks (single panel, 20-50 samples). Combined panels: 3-4 weeks. Custom panels: add 2-4 weeks for method development. Large studies (200+ samples): 4-6 weeks. Expedited (manuscript revisions): 1-2 weeks. Sample integrity confirmed within 1 business day; preliminary QC summary within first week.

Selected Publications Using Targeted Metabolomics

Central biogenic amine deficiency with concomitant exploratory behavioral deficits in Dnajc12 knock-out mice

Deng, I.B., et al.

Journal: NPJ Parkinson's Disease

Year: 2025

DOI: https://doi.org/10.1038/s41531-025-00991-4

B cell-intrinsic epigenetic modulation of antibody responses by dietary fiber-derived short-chain fatty acids

Sanchez, H.N., Moroney, J.B., Gan, H., et al.

Journal: Nature Communications

Year: 2020

DOI: https://doi.org/10.1038/s41467-019-13603-6

Glucocorticoid-induced osteoporosis is prevented by dietary prune in female mice

Chargo, N.J., Neugebauer, K., Guzior, D.V., et al.

Journal: Frontiers in Cell and Developmental Biology

Year: 2024

DOI: https://doi.org/10.3389/fcell.2023.1324649

Metabolites and Genes behind Cardiac Metabolic Remodeling in Mice with Type 1 Diabetes Mellitus

Kambis, T.N., Shahshahan, H.R., & Mishra, P.K.

Journal: International Journal of Molecular Sciences

Year: 2022

DOI: https://doi.org/10.3390/ijms23031392

Quantification of choline in serum and plasma using a clinical nuclear magnetic resonance analyzer

Garcia, E., Shalaurova, I., Matyus, S.P., et al.

Journal: Clinica Chimica Acta

Year: 2022

DOI: https://doi.org/10.1016/j.cca.2021.11.031

Sarcosine Is Uniquely Modulated by Aging and Dietary Restriction in Rodents and Humans

Walters, R.O., et al.

Journal: Cell Reports

Year: 2018

DOI: https://doi.org/10.1016/j.celrep.2018.09.065

NUDT22 promotes cancer growth through pyrimidine salvage and the TCA cycle

Walter, M., Mayr, F., Hanna, B.M.F., et al.

Journal: Oncogene

Year: 2022

DOI: https://doi.org/10.1038/s41388-022-02437-w

Neddylation is required for perinatal cardiac development through stimulation of metabolic maturation

Zou, J., Wang, W., et al.

Journal: Cell Reports

Year: 2023

DOI: https://doi.org/10.1016/j.celrep.2023.112018

Sex modifies the impact of type 2 diabetes mellitus on the murine whole brain metabolome

Norman, J.E., Nuthikattu, S., Milenkovic, D., & Villablanca, A.C.

Journal: Metabolites

Year: 2023

DOI: https://doi.org/10.3390/metabo13091012

Comparing the metabolic signatures of obesity defined by waist circumference, waist-hip ratio, or BMI

Al Hariri, M., et al.

Journal: Obesity

Year: 2024

DOI: https://doi.org/10.1002/oby.24070

For Research Use Only. Not for use in diagnostic procedures.
inquiry

Get Your Custom Quote

Connect with Creative Proteomics Contact UsContact Us
return-top